DNP International has announced the ownership of a manufacturing facility that will further fuel its strong presence in the nutritional supplement industry. The facility, located in the Jiangsu province of eastern China, allows DNP to advance its goals of guaranteeing consistent quality, competitive pricing and a stable supply of raw materials.
“It is important for our customers to know we are controlling the formation of Creatine products from the start of the manufacturing process to the final delivery,” said David Ji, president of DNP International. “The results we anticipate are improved quality, lower pricing and more availability on a consistent level.”
The Jiangsu facility has been in operation since last year prior to DNP taking ownership. DNP’s initial focus is to produce a line of Creatine products, which is currently in high demand. With the facility’s current capacity, DNP will be able to produce more than 4,000 metric tons of its Creatine line of products, including 3,000 metric tons for its Monohydrate variation. Some of the products that customers may submit their blanket orders for include Creatine Anhydrous, Creatine Citrate, Creatine Gluconate, Creatine Phosphate, Creatine Ethyl Ester, Creatine Malate, Creatine Orotate and Creatine Alpha Keto Glutarate. Some of the products are already available for purchase and others will be available later this month. Customers may also request a sample prior to purchasing any of the products through their local sales representative.
About DNP International
DNP International imports and distributes raw material ingredients to manufacturers in the nutritional supplements, food, beverage, feed, cosmetics and pharmaceutical industries. Founded in 1994, DNP is one of the largest suppliers of raw materials in the United States and sources over 2,500 different ingredients. DNP is headquartered in Southern California and has offices in Los Angeles, Chicago, New Jersey and Shanghai, China. For more information, visit www.dnpint.com.